We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Rectangle Image
Product News

Grifols, Beckman Coulter Enter Exclusive Distribution Agreement

Rectangle Image
Product News

Grifols, Beckman Coulter Enter Exclusive Distribution Agreement

Grifols and Beckman Coulter Inc., have entered into an exclusive, long-term agreement for the global distribution of Grifols’ hemostasis instruments, reagents and consumables.

"Grifols continues to execute its strategy in growing the Specialty Diagnostics line. Our hemostasis product line complements Beckman Coulter’s broad portfolio of products and services for the core laboratory," said Carsten Schroeder, Grifols President of Diagnostic Commercial Operations.

"Beckman Coulter’s long-term partnership with Grifols expands our extensive diagnostic product offering and further supports our position as a partner of choice with hospitals and clinical laboratories across the world,” stated Arnd Kaldowski, President of Beckman Coulter Diagnostics.

“Grifols’ hemostasis product line, focused on reliability and efficiency, combined with our global distribution network, automation leadership and clinical informatics solutions for the core laboratory, provide our customers with even more solutions to deliver better patient care,” added Kevin Chance, President of Products and Services for Beckman Coulter Diagnostics.

“We are extremely excited about the collaboration with Beckman Coulter. The agreement leverages Grifols’ strength in manufacturing reliable instruments and reagents with that of Beckman Coulter’s commercial strength,” added Oriol Duñach, Grifols President of Diagnostic Industrial Division.  

Beckman Coulter and Grifols anticipate first commercializing systems under this distribution agreement in Europe in early 2018.


Advertisement